Bpifrance

Bpifrance Financement S.A. is a French financial institution that provides a range of financing solutions and support services aimed at fostering the growth of startups, small and medium-sized enterprises (SMEs), and mid-cap companies. It offers various financial products, including medium to long-term loans, export insurance, and leasing options for both tangible and intangible assets. Additionally, Bpifrance supports companies through consulting services, guarantees for bank financing, and training for executives. The organization also engages in direct investments and manages funds aimed at enhancing the financial landscape for businesses at different stages of their development. Established in 1980 and based in Maisons-Alfort, France, Bpifrance was formerly known as OSEO S.A. and rebranded in July 2013. It operates as a subsidiary of Bpifrance SA, reinforcing its commitment to bolstering the French economy through diversified financial solutions.

Céline André

Investment Director

Adonis Arnaud

Junior Investment Manager

Laurent Arthaud

Managing Director

Françis Aymard

Investment Director

Simon Beauroy

Director

Isabelle Bebear

Director for International and University

Soukanda Bentaleb

Investment Officer

Pascal Bordat

Investment Director

Nathalie Carmona

Associate

Yoann Caujolle

Portfolio Director

Nicolas Ceria

Associate

Ménelé Chesnot

Senior Investment Director

Samuel Dalens

Investment Director

Florent Debienne

Managing Director | Head of Technology Funds Investments

Christian Deblaye

Deputy MD

Luc Doyennel

Investment Director

Nicolas Dufourcq

CEO

Jean-Yves Duriez

Investment Director

Antoine Emmanuelli

Partnership Director

Francis Estellat

Senior Investment Director

Alain Fakhoury

Investment Director Bretagne

Stephen Fargis

Associate

Arnaud Fauquembergue

Investment Manager

Olivier Fosse

Investment Director Alsace Champagne-Ardenne Lorraine

Jean-Marie Fougeray

Investment Director Bretagne

Stéphanie Frachet

Investment Director

Ronan Frefield

Portfolio Director

Laurence Gauthier

Senior Investment Director Bourgogne Franche-Comté

Xavier Gelot

Director of Fonds de Renforcement des PME

Emmanuelle Gervais

Senior Investment Director

Isabelle Ginestet-Naudin

Deputy MD and Director of Sectorial Funds

Vanessa Giraud

Managing Director

Alessandro Gonella

Director

José Gonzalo

Executive Director Mid and Large Cap Direction

Alexis Guinard

Investment Director

Raphaël Guterman

Associate

Yonel Génin

Partnership Director

Luc Heinrich

MD

Hubert Hernandez

Investment Director

Hortense Jacon

Investment Associate

Véronique Jacq

Managing Director

Jean-René Jégou

Director of the Regional Funds Department

Pascal Lagarde

Director

Caroline Lebel

Senior Associate

Eric Lefebvre

Director

Ronan Lefort

Investment Director

Arnaud Legardeur

Investment Director

Christian Leonetti

Investment Director

Olivier Levy

Director of East private equity Interregional Network

Cedric Lowenbach

Director of Operations

Arielle Marsaud

Associate

Alex Marvaldi

Partner

Laure Michel

Investment Director

Maud Moulin

Portfolio Director

Sébastien Moynot

Investment Director and Member of the Management Board

Philippe Mutricy

Deputy MD

Valérie de la Ménardière

Investment Director

Alexandre Ossola

MD

Stanislas Panhard

Senior Investment Director

Nicolas Parpex

Senior Investment Director

Sophie Perette

Portfolio Director Alsace Champagne-Ardenne Lorraine

Thibault Peroys

Investment Director

Axel Piriou

Senior Investment Manager

Marc Prévôt

Director of North Private Equity Interregional Network

Matthieu Rabeisen

Portfolio Director

Sarah Roeland

Investment Manager

Stéphane Romang

Investment Director

Thibaut Roulon

Investment Director

Julie Régnier

Senior Investment Manager Alsace Champagne-Ardenne Lorraine

Eduardo Sampaio

Portfolio Director

Nadia Sarri

Investment Director

Gilles Schang

Deputy Managing Director

Nicolas de La Serre

Investment Director Pays de la Loire

Thierry Sommelet

MD

Vincent Stievenard

Investment Director and Director of North Private Equity Interregional Network

Xavier Tessier

Director

Gabrielle Tetart

Senior Investment Manager and Associate

Tuan Tran

Investment Director

Alain Tueux

Investment Director

Stanislas de Tymowski

Associate

Adrien Vasseur

Portfolio Director

Benoît Villain

Senior Investment Manager

Philippe Vuarchex

Associate

Stéphanie Vuillaume

Associate

Romain Vérani

Associate

Samuel Waddell

Associate

Past deals in Biofuel

Kyanos

Seed Round in 2021
High value polysaccharides and pigments produced with high-output micro-algae and vertical photo-reactors.

Deinove SA

Post in 2020
Deinove SA is a France-based company active in the renewable fuels sector. It specializes in the development and commercial exploitation of processes for production of biofuels and other compounds of industrial or pharmaceutical value.

Microphyt

Venture Round in 2019
Microphyt is a company based in Baillargues, France, that specializes in the research, development, production, and marketing of microalgae and other photosynthetic microorganisms. Founded in 2007, Microphyt caters to various markets, including beauty care, food, health, and energy. The company focuses on creating natural algae-based products that support weight loss and promote brain health, while also engaging in industrial farming of microalgae.

TOOPI Organics

Pre Seed Round in 2019
Toopi Organics SAS is a French company that focuses on manufacturing biostimulants for agriculture derived from human urine. Established in 2019 and based in Langon, France, the company produces products such as Arbop and Vitip, which are designed to enhance plant growth. By utilizing human urine as a resource, Toopi Organics operates in a unique market segment that promotes sustainable agricultural practices.

Deinove SA

Post in 2019
Deinove SA is a France-based company active in the renewable fuels sector. It specializes in the development and commercial exploitation of processes for production of biofuels and other compounds of industrial or pharmaceutical value.

Alkion BioInnovations

Grant in 2019
In 2011, Alkion BioPharma has been created to revolutionize the secondary metabolims production for cancer therapies. Imperial Innovations, a team of Imperial College researchers and business professionals joined together to develop the technologies able to transform the non-GMO plants into a natural biorefinery. Quickly the technological platform received strong interests from the cosmetic community and the company signed research contracts to develop new disruptive cosmetic ingredients. Four years after inception, with a strong commercial pipeline, Alkion BioPharma has been acquired by Evonik Industries AG for cosmetic & food supplements applications. The new company Alkion BioInnovations was created in March 2017 in order to develop disruptive nutrition, non-cosmetic oil, and agrochemical solutions. The company owns exclusive rights on this applications.

HySiLabs

Venture Round in 2018
HySiLabs SAS, founded in 2015 and based in Aix en Provence, France, specializes in generating hydrogen on demand through a unique process that combines two stable liquids. The company's innovative technology utilizes a hydrogen-based liquid carrier system, allowing for the release and consumption of hydrogen without generating emissions. This system retains the benefits of an energy-dense hydrogen vector while avoiding common storage challenges. HySiLabs' solution offers a safe and efficient logistics supply chain comparable to existing liquid fuels, enabling transportation at ambient temperature and pressure. The versatility of its technology allows for a wide range of applications across various markets, providing a flexible and user-friendly energy source.

Alkion BioInnovations

Grant in 2016
In 2011, Alkion BioPharma has been created to revolutionize the secondary metabolims production for cancer therapies. Imperial Innovations, a team of Imperial College researchers and business professionals joined together to develop the technologies able to transform the non-GMO plants into a natural biorefinery. Quickly the technological platform received strong interests from the cosmetic community and the company signed research contracts to develop new disruptive cosmetic ingredients. Four years after inception, with a strong commercial pipeline, Alkion BioPharma has been acquired by Evonik Industries AG for cosmetic & food supplements applications. The new company Alkion BioInnovations was created in March 2017 in order to develop disruptive nutrition, non-cosmetic oil, and agrochemical solutions. The company owns exclusive rights on this applications.

Global Bioenergies

Post in 2015
Global Bioenergies SA is a French company established in 2008, specializing in the development of a biological process to convert renewable resources into isobutene, a crucial petrochemical building block. The company is unique in Europe for its innovative approach to producing hydrocarbons through fermentation, focusing not only on isobutene but also on other gaseous olefins such as propylene and butadiene. In addition to its production efforts, Global Bioenergies offers engineering services related to gas fermentation processes and is engaged in converting industrial emissions and gaseous carbon sources into valuable chemical compounds. The company operates an industrial pilot and is constructing a demonstration plant in Germany, while preparing for its first full-scale facility through a joint venture with Cristal Union called IBN-One.